First robotic exoskeleton cleared for use with stroke and spinal cord injury levels to C7
RICHMOND, Calif., April 04, 2016 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries at levels T4 to L5, and individuals with spinal cord injuries at levels of T3 to C7 (ASIA D), in accordance with device’s labeling. The Ekso GT is the first exoskeleton cleared by the FDA for use with stroke patients. Continue Reading »
LOS ANGELES — There are tiny rat treadmills in the lab. And jars of Nutella, also for the rats. There are video cameras, heaps of electrodes, and instruments for slicing frozen brain tissue.
And in the center of it all: Reggie Edgerton, a 75-year-old physiologist who has spent four decades on a stubborn quest to prove, in the face of scientific ridicule, that severed spinal cords can be jolted back to life — and that paralyzed patients need not be paralyzed forever.
After inventing the first-ever untethered bionic exoskeleton, he broke from his former company. Now this inventor is back with another breakthrough.
The man behind the first untethered bionic exoskeleton is back with a new robotic suit.
Homayoon Kazerooni led the team that developed BLEEX, the first viable actuated suit that didn’t need to be plugged in, back in 2005. Groundbreaking at the time, the technology was eventually spun off into Ekso Bionics, long a darling of the Bay Area hardware scene. Continue Reading »
Injuries to the spinal cord partially or completely disrupt the neural pathways between the brain and the limbs. The consequences for the representation of the affected limbs in the brain can be drastic. Researchers have now measured how severely this representation is affected.
A strange sensation, but familiar to anyone who has ever been given local anaesthesia and watched while a doctor operated on their leg or arm: in that moment, your own body part seems foreign, as if it doesn’t belong to your body. One reason for this is that the brain still knows which position the limb occupied before the local anaesthetic took effect. As soon as it wears off, the spooky sensation disappears. Continue Reading »
State-of-the-Art Device Allows Individuals with Spinal Cord Injury to Stand and Walk; Regulatory Clearances in USA and Europe Pave the Way for Commercialization
CLEVELAND, March 10, 2016 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that the U.S. Food and Drug Administration (FDA) has given clearance to market and sell the Indego® exoskeleton for clinical and personal use in the United States. The company intends to commercially launch the device in the United States in the coming months. Continue Reading »
American insurance providers are being faced with an interesting health care debate: Should walking be considered a need?
At the center of this debate are exoskeletons — motorized devices that allows those with spinal cord injuries to stand upright and walk. So far, the ReWalk system is the only exoskeleton in the United States that has been approved by the FDA. However, it costs close to $70,000.
“Bionic spinal cord” could give extra function and mobility to users of mobility assist devices.
A ‘revolutionary’ device implanted in a brain blood vessel may one day enable people with spinal cord injuries to walk again, say Melbourne researchers.
The brain machine interface consists of a stent-based electrode (stentrode), which is implanted within a blood vessel next to the brain, and records the type of neural activity that has been shown in pre-clinical trials to move limbs through an exoskeleton or to control bionic limbs. Continue Reading »
A joint team from Kessler Foundation and the New Jersey Institute of Technology (NJIT) is developing new applications for wearable robotic exoskeleton devices with a $5 million federal grant from the National Institute on Disability, Independent Living and Rehabilitation Research.
Researchers from the two institutions are working together on the next generation of robotic exoskeletons to improve mobility and to enable safer, more independent functioning for people with spinal cord injuries (SCI), Duchenne Muscular Dystrophy and stroke. The team will also evaluate the efficacy of existing robots for restoring and expanding mobility to upper and lower extremities. Continue Reading »
Even when life becomes too hectic for Amy Van Dyken-Rouen, she finds a way to progress in her spinal cord rehabilitation.
For 2 ½ months, she was traveling so extensively for speaking engagements that her weekly work with physical therapist Al Biemond at Barrow Neurological Institute in Phoenix had to be put on hold.
Thrust into a role as a spokeswoman for spinal cord injury research because of the fame that comes with six Olympic gold medals, Van Dyken-Rouen accepts her obligation to fly around the country — never easy or painless — to spread a message that many other paraplegics aren’t invited to deliver. Continue Reading »